|
Xylo-pfanDrug - Xylo-pfan The trade name of the product as shown on the labeling.
Dosage -
POWDER; ORAL
Active Ingredient(s) -
Xylose
Strength -
25GM/BOT
Applicant -
SAVAGE LABS
New Drug Application (NDA) Number -
017605
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Savage Laboratories Inc Div Altana Inc
Xylo-pfan
Xenon Xe 133-v.S.S. 10mci/vial Gas; Inhalation
Xenon Xe 133 6.3mci/ml Injectable; Injection Xenon Xe 133 1.3-1.7 Ci/amp Injectable; Injection Xeneisol 18-25mci/amp Solution; Inhalation, Injection Xylo-pfan 25gm/bot Powder; Oral Xenon Xe 133 20mci/vial Gas; Inhalation Xenon Xe 133 0.25-5 Ci/amp Gas; Inhalation Xenon Xe 133 5-100 Ci/cylinder Gas; Inhalation Xenon Xe 133 10mci/vial Gas; Inhalation Xenon Xe 133 20mci/vial Gas; Inhalation NewDrugInformation |